相关实验视频

Updated: Jan 10, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

3.1K

结合治疗质母细胞瘤与Temozolomide (TMZ) 加上5-Ethynyl-2'-deoxyuridine (EdU) 的结合治疗

Humeyra Kaanoglu1, Yasemin K Akyel1, Adebimpe Adefolaju2

  • 1Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

bioRxiv : the preprint server for biology
|November 24, 2025
PubMed
概括

与单一治疗相比,temozolomide (TMZ) 和EDU的组合显示出对质母细胞瘤 (GBM) 脑瘤的疗效有所改善. 这种新型疗法有可能在GBM患者中获得更好的结果.

更多相关视频

Evaluating In Vitro DNA Damage Using Comet Assay10:43

Evaluating In Vitro DNA Damage Using Comet Assay

Published on: October 11, 2017

39.3K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.0K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K